4.7 Article

A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications

Journal

Publisher

MDPI
DOI: 10.3390/ijms23063135

Keywords

B; coagulans; CAZymes; bacteriocins; CRISPR-Cas systems

Funding

  1. PRIN 2017-PANACEA [CUP E69E19000530001]
  2. GoodbyWaste: ObtainGOOD products-exploit BY-products-reduce WASTE, Italy [MIUR 2017-JTNK78.006]
  3. Novo Nordisk Foundation/Hallas-Moeller Ascending Investigator Grant [NNF17OC0031154]

Ask authors/readers for more resources

This study presents a comparative genomic analysis of nine strains of Weizmannia coagulans, focusing on their repertoire of Carbohydrate-Active enZymes (CAZymes), secretion systems, and resistance mechanisms. The study also analyzes the CRISPR immune system and CRISPR-associated (Cas) genes. Overall, this research provides valuable insights into the genomic diversity of W. coagulans and its potential applications in biotechnology.
The production of biochemicals requires the use of microbial strains with efficient substrate conversion and excellent environmental robustness, such as Weizmannia coagulans species. So far, the genomes of 47 strains have been sequenced. Herein, we report a comparative genomic analysis of nine strains on the full repertoire of Carbohydrate-Active enZymes (CAZymes), secretion systems, and resistance mechanisms to environmental challenges. Moreover, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) immune system along with CRISPR-associated (Cas) genes, was also analyzed. Overall, this study expands our understanding of the strain's genomic diversity of W. coagulans to fully exploit its potential in biotechnological applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available